CLCM
KITE

Crawford Lake Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Crawford Lake Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,000
Closed -$1.1M – 158
2017
Q1 		$1.1M Buy
+14,000
New +$866K 0.44% 51

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Crawford Lake Capital Management's KITE Position: Q2 2017 in Review

Crawford Lake Capital Management sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 14,000 shares — an estimated $1.1M sold.

Crawford Lake Capital Management first reported a position in KITE in Q1 2017 and held it in 1 quarter. The position peaked at $1.1M in Q1 2017. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

  • Crawford Lake Capital Management reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
  • Crawford Lake Capital Management sold 14,000 Kite Pharma, Inc. shares in Q2 2017, an estimated $1.1M.
  • Crawford Lake Capital Management first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 1 quarter.
  • Crawford Lake Capital Management's Kite Pharma, Inc. position peaked at $1.1M in Q1 2017.
  • 220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Crawford Lake Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.